US6518482B2
(en)
|
1994-09-13 |
2003-02-11 |
American National Red Cross |
Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor
|
US5880327A
(en)
*
|
1994-09-21 |
1999-03-09 |
American National Red Cross |
Transgenic mammals expressing human coagulation factor VIII
|
US6613958B1
(en)
|
1997-12-19 |
2003-09-02 |
Wyeth |
Transgenic mouse model for degeneration of type II collagen in joints
|
GB9807464D0
(en)
*
|
1998-04-07 |
1998-06-10 |
Pharming Bv |
Purification of human acid µ-glucosidase
|
US20040117863A1
(en)
*
|
1998-09-18 |
2004-06-17 |
Edge Michael D. |
Transgenically produced fusion proteins
|
US7030289B2
(en)
|
1998-11-19 |
2006-04-18 |
Ppl Therapeutics (Scotland) Ltd |
Stabilization of milk from transgenic animals
|
AU765315B2
(en)
*
|
1998-11-19 |
2003-09-18 |
Pharming Intellectual Property Bv |
Stabilisation of milk from transgenic animals
|
US7208576B2
(en)
|
1999-01-06 |
2007-04-24 |
Merrimack Pharmaceuticals, Inc. |
Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
|
CA2354638C
(en)
*
|
1999-01-06 |
2013-03-19 |
Atlantic Biopharmaceuticals, Inc. |
Expression of secreted human alpha-fetoprotein in transgenic animals
|
US6183803B1
(en)
|
1999-06-11 |
2001-02-06 |
Biosante Pharmaceuticals, Inc. |
Method for processing milk
|
AU6913600A
(en)
*
|
1999-08-19 |
2001-03-13 |
Us Transgenics, Inc. |
Transgenic prothrombin and related thrombin precursors and transgenics, methods,compositions, uses and the like relating thereto
|
KR20020073127A
(ko)
*
|
1999-09-17 |
2002-09-19 |
겐자임 트랜스제닉스 코포레이션 |
형질전환에 의하여 생성된 융합 단백질
|
WO2001022810A2
(en)
*
|
1999-09-28 |
2001-04-05 |
Us Transgenics, Inc. |
Transgenic animals expressing von willebrand factor (vwf) and vwf-related polypeptides
|
WO2001027303A1
(en)
*
|
1999-10-12 |
2001-04-19 |
The University Of North Carolina At Chapel Hill |
Adeno-associated virus vectors encoding factor viii and methods of using the same
|
US20030129745A1
(en)
*
|
1999-10-28 |
2003-07-10 |
Robl James M. |
Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
|
AU782067B2
(en)
|
1999-12-20 |
2005-06-30 |
Immunex Corporation |
TWEAK receptor
|
US20030046716A1
(en)
*
|
2000-06-19 |
2003-03-06 |
Yann Echelard |
Transgenically produced platelet derived growth factor
|
US20020073441A1
(en)
|
2000-12-13 |
2002-06-13 |
Ross Brian D. |
Compositions and methods for detecting proteolytic activity
|
WO2002072023A2
(en)
*
|
2001-03-12 |
2002-09-19 |
Progenetics Llc |
Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses
|
US7220718B2
(en)
*
|
2001-08-03 |
2007-05-22 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oral treatment of hemophilia
|
EP1585386A4
(de)
*
|
2002-02-20 |
2009-09-02 |
American Integrated Biolog Inc |
Rekombinante produktion im speichel
|
US20040117862A1
(en)
*
|
2002-03-11 |
2004-06-17 |
Cooper Julian D. |
Production of high levels of transgenic factor VII with engineered stability and its therapeutic uses
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
EP1497418B1
(de)
|
2002-04-19 |
2012-10-17 |
Verenium Corporation |
Phospholipasen, diese codierende nukleinsäuren sowie verfahren zu ihrer herstellung und verwendung
|
EP3023498B1
(de)
|
2003-03-06 |
2018-11-28 |
BASF Enzymes LLC |
Amylasen, nukleinsäuren zur codierung davon und verfahren zur herstellung und verwendung davon
|
MX295545B
(es)
|
2003-03-07 |
2012-02-03 |
Diversa Corp |
Hidrolasas, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas.
|
US7592434B2
(en)
|
2003-04-04 |
2009-09-22 |
Verenium Corporation |
Pectate lyases, nucleic encoding them and methods for making and using them
|
US7514593B2
(en)
|
2003-05-30 |
2009-04-07 |
The University Of North Carolina At Chapel Hill |
Animal model for chronic obstructive pulmonary disease and cystic fibrosis
|
EP2404931A1
(de)
|
2003-07-02 |
2012-01-11 |
Verenium Corporation |
Glucanasen, Nukleinsäuren, die diese codieren, und Verfahren zu deren Herstellung und Verwendung
|
CA2535526C
(en)
|
2003-08-11 |
2015-09-29 |
Diversa Corporation |
Laccases, nucleic acids encoding them and methods for making and using them
|
EP1699469B1
(de)
*
|
2003-12-03 |
2010-04-07 |
University of Rochester |
Rekombinanter faktor viii mit erhöhter spezifischer aktivität
|
US7667089B2
(en)
*
|
2004-04-09 |
2010-02-23 |
National Chung Hsing University |
Transgenic mammal secreting B-domain deleted human FVII in its milk
|
AU2005264938B2
(en)
|
2004-06-16 |
2011-11-24 |
Verenium Corporation |
Compositions and methods for enzymatic decolorization of chlorophyll
|
US7566701B2
(en)
*
|
2004-09-07 |
2009-07-28 |
Archemix Corp. |
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
|
KR20070101227A
(ko)
|
2004-09-07 |
2007-10-16 |
아케믹스 코포레이션 |
폰 빌레브란트 인자에 대한 앱타머 및 이의 혈전증치료제로서의 용도
|
AU2005282380A1
(en)
*
|
2004-09-07 |
2006-03-16 |
Archemix Corp. |
Aptamer medicinal chemistry
|
WO2006099207A2
(en)
|
2005-03-10 |
2006-09-21 |
Diversa Corporation |
Lyase enzymes, nucleic acids encoding them and methods for making and using them
|
NZ594810A
(en)
|
2005-03-15 |
2012-12-21 |
Verenium Corp |
Cellulases, nucleic acids encoding them and methods for making and using them
|
US20070061899A1
(en)
*
|
2005-04-13 |
2007-03-15 |
The Trustees Of Columbia University In The City Of New York |
Transgenic mammal with constitutive, tissue-specific cytokine expression and use as a cancer model
|
US20070011752A1
(en)
*
|
2005-05-06 |
2007-01-11 |
American Integrated Biologics, Inc. |
Production of human proteins in transgenic animal saliva
|
WO2007092314A2
(en)
|
2006-02-02 |
2007-08-16 |
Verenium Corporation |
Esterases and related nucleic acids and methods
|
DK2450439T3
(da)
|
2006-02-10 |
2014-02-10 |
Verenium Corp |
Cellulosenedbrydende enzymer, nucleinsyrer, der koder for dem, og fremgangsmåder til at fremstille og benytte dem
|
EP2548955A1
(de)
|
2006-02-14 |
2013-01-23 |
Verenium Corporation |
Xylanasen, Nukleinsäuren, die diese codieren, und Verfahren zu deren Herstellung und Verwendung
|
EP2112227B1
(de)
|
2006-03-07 |
2013-05-15 |
Cargill, Incorporated |
Aldolasen, Nukleinsäuren zu ihrer Kodierung sowie Verfahren zu ihrer Herstellung und Verwendung
|
KR101588539B1
(ko)
|
2006-03-07 |
2016-01-25 |
바스프 엔자임스 엘엘씨 |
알돌라제, 이것을 코딩하는 핵산과 그 제조 방법 및 사용 방법
|
US7663019B2
(en)
*
|
2006-05-24 |
2010-02-16 |
North Carolina State University |
Transgenic snakes and methods of making
|
FR2901707B1
(fr)
|
2006-05-31 |
2017-09-29 |
Lab Francais Du Fractionnement |
Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
|
US8124831B2
(en)
*
|
2006-07-06 |
2012-02-28 |
Duke University |
Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
|
FR2904558B1
(fr)
*
|
2006-08-01 |
2008-10-17 |
Lab Francais Du Fractionnement |
"composition de facteur vii recombinant ou transgenique, presentant majoritairement des formes glycanniques biantennees, bisialylees et non fucosylees"
|
BRPI0714876B1
(pt)
|
2006-08-04 |
2022-04-19 |
Verenium Corporation |
Ácido nucleico isolado, sintético ou recombinante, cassete de expressão, vetor ou veículo de clonagem, célula bacteriana, fúngica ou de levedura transformada, polipeptídeo isolado, sintético ou recombinante, composição, bem como métodos de produção e de usos dos mesmos
|
CN113789316A
(zh)
|
2006-09-21 |
2021-12-14 |
巴斯夫酶有限责任公司 |
肌醇六磷酸酶、编码它们的核酸及制备和使用它们的方法
|
WO2008036863A2
(en)
|
2006-09-21 |
2008-03-27 |
Verenium Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
CA2673525C
(en)
|
2006-12-21 |
2017-12-05 |
Verenium Corporation |
Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
|
FR2910786B1
(fr)
*
|
2006-12-29 |
2017-08-11 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) |
"procede d'extraction d'une proteine presente dans du lait"
|
US20090203766A1
(en)
*
|
2007-06-01 |
2009-08-13 |
Archemix Corp. |
vWF aptamer formulations and methods for use
|
FR2920024B1
(fr)
*
|
2007-08-14 |
2012-12-14 |
Lfb Biotechnologies |
Procede de purification ou de detection d'une proteine cible
|
FR2920429B1
(fr)
*
|
2007-08-30 |
2012-10-05 |
Lfb Biotechnologies |
Procede de purification du facteur viii et du facteur von willebrand
|
WO2009045627A2
(en)
|
2007-10-03 |
2009-04-09 |
Verenium Corporation |
Xylanases, nucleic acids encoding them and methods for making and using them
|
CA2739011A1
(en)
*
|
2007-10-29 |
2009-05-07 |
The Regents Of The University Of California |
Osteoarthritis gene therapy
|
WO2009058446A1
(en)
*
|
2007-11-01 |
2009-05-07 |
University Of Rochester |
Recombinant factor viii having increased stability
|
JP5624891B2
(ja)
*
|
2007-12-31 |
2014-11-12 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
ヒト血液凝固因子を発現するトランスジェニック非ヒト動物
|
JP5563990B2
(ja)
|
2008-01-03 |
2014-07-30 |
ヴェレニウム コーポレイション |
トランスフェラーゼおよびオキシドレダクターゼ、それらをコードする核酸並びにそれらを製造および使用する方法
|
US8541220B2
(en)
|
2008-01-03 |
2013-09-24 |
Verenium Corporation |
Isomerases, nucleic acids encoding them and methods for making and using them
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
EP2326720B1
(de)
|
2008-09-15 |
2018-03-21 |
F. Hoffmann-La Roche AG |
Zusammensetzungen und verfahren zur regulierung einer zellosmolarität
|
FR2940655B1
(fr)
|
2008-12-31 |
2011-02-18 |
Lfb Biotechnologies |
Peptides isoles de facteur vii de lapin.
|
FR2942231B1
(fr)
|
2009-02-19 |
2015-03-20 |
Lfb Biotechnologies |
Acides nucleiques se liant specifiquement au facteur vii/viia humain, et utilisations
|
FR2942232B1
(fr)
*
|
2009-02-19 |
2015-03-13 |
Lfb Biotechnologies |
Moyens pour la purification d'une proteine de la coagulation et procedes pour sa mise en oeuvre
|
CN102459303B
(zh)
|
2009-05-21 |
2016-06-29 |
巴斯夫酶有限责任公司 |
肌醇六磷酸酶、编码它们的核酸及制备和使用它们的方法
|
FR2948664B1
(fr)
|
2009-07-31 |
2013-11-01 |
Lfb Biotechnologies |
Procede pour la purification de proteines de la coagulation a domaine gla
|
FR2948665B1
(fr)
|
2009-07-31 |
2011-09-23 |
Lfb Biotechnologies |
Procede pour la purification de proteines de la coagulation a domaine gla actives
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
FR2983212A1
(fr)
|
2011-11-28 |
2013-05-31 |
Lfb Biotechnologies |
Aptameres anti-fh, procede pour leur obtention et utilisations
|
FR3011250A1
(fr)
|
2013-09-30 |
2015-04-03 |
Lab Francais Du Fractionnement |
Acides nucleiques se liant specifiquement au facteur ix/ixa humain, et utilisations
|
CN104313052A
(zh)
*
|
2014-10-29 |
2015-01-28 |
上海滔滔转基因工程股份有限公司 |
一种利用vWF稳定表达人凝血因子VIII的乳腺特异共表达载体
|
US11266129B2
(en)
|
2019-11-05 |
2022-03-08 |
Versiti Blood Research Institute Foundation, Inc. |
Murine model of fetal/neonatal alloimmune thrombocytopenia
|
JP2023500896A
(ja)
|
2019-11-05 |
2023-01-11 |
ヴァーシティ ブラッド リサーチ インスティテュート ファウンデーション, インコーポレイテッド |
胎児/新生児同種抗体血小板減少症のマウスモデル
|